EARNEST Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-48
| Closed | -$39.5K | – | 920 |
|
|
2023
Q3 | $39.5K | Hold |
48
| – | – | ﹤0.01% | 390 |
|
|
2023
Q2 | $34.5K | Hold |
48
| – | – | ﹤0.01% | 392 |
|
|
2023
Q1 | $39.4K | Hold |
48
| – | – | ﹤0.01% | 366 |
|
|
2022
Q4 | $34.6K | Hold |
48
| – | – | ﹤0.01% | 382 |
|
|
2022
Q3 | $33K | Hold |
48
| – | – | ﹤0.01% | 372 |
|
|
2022
Q2 | $28K | Hold |
48
| – | – | ﹤0.01% | 404 |
|
|
2022
Q1 | $34K | Hold |
48
| – | – | ﹤0.01% | 388 |
|
|
2021
Q4 | $30K | Hold |
48
| – | – | ﹤0.01% | 419 |
|
|
2021
Q3 | $29K | Hold |
48
| – | – | ﹤0.01% | 413 |
|
|
2021
Q2 | $27K | Hold |
48
| – | – | ﹤0.01% | 422 |
|
|
2021
Q1 | $23K | Hold |
48
| – | – | ﹤0.01% | 442 |
|
|
2020
Q4 | $23K | Hold |
48
| – | – | ﹤0.01% | 423 |
|
|
2020
Q3 | $27K | Buy |
48
+12
| +33% | +$6.75K | ﹤0.01% | 364 |
|
|
2020
Q2 | $22K | Hold |
36
| – | – | ﹤0.01% | 385 |
|
|
2020
Q1 | $18K | Hold |
36
| – | – | ﹤0.01% | 403 |
|
|
2019
Q4 | $14K | Hold |
36
| – | – | ﹤0.01% | 516 |
|
|
2019
Q3 | $10K | Hold |
36
| – | – | ﹤0.01% | 586 |
|
|
2019
Q2 | $11K | Hold |
36
| – | – | ﹤0.01% | 561 |
|
|
2019
Q1 | $15K | Hold |
36
| – | – | ﹤0.01% | 492 |
|
|
2018
Q4 | $13K | Hold |
36
| – | – | ﹤0.01% | 486 |
|
|
2018
Q3 | $15K | Hold |
36
| – | – | ﹤0.01% | 490 |
|
|
2018
Q2 | $12K | Hold |
36
| – | – | ﹤0.01% | 531 |
|
|
2018
Q1 | $12K | Hold |
36
| – | – | ﹤0.01% | 527 |
|
|
2017
Q4 | $14K | Buy |
+36
| New | +$14K | ﹤0.01% | 486 |
|
|
2017
Q1 | – | Sell |
-36
| Closed | -$13K | – | 757 |
|
|
2016
Q4 | $13K | Buy |
+36
| New | +$13K | ﹤0.01% | 473 |
|